CN109641006B - 影响肠道微生物组成的微生物类胡萝卜素 - Google Patents

影响肠道微生物组成的微生物类胡萝卜素 Download PDF

Info

Publication number
CN109641006B
CN109641006B CN201780051160.0A CN201780051160A CN109641006B CN 109641006 B CN109641006 B CN 109641006B CN 201780051160 A CN201780051160 A CN 201780051160A CN 109641006 B CN109641006 B CN 109641006B
Authority
CN
China
Prior art keywords
carotenoids
gut
microbial
intestinal
carotenoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780051160.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN109641006A (zh
Inventor
S·波赛米尔斯
C·杜斯伯格
I·品贺洛
S·波尔卡
P·梵登阿必勒
M·马尔佐拉蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Resource Management Health NV MRM Health
Original Assignee
Microbial Resource Management Health NV MRM Health
Prodigest BVBA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Resource Management Health NV MRM Health, Prodigest BVBA filed Critical Microbial Resource Management Health NV MRM Health
Publication of CN109641006A publication Critical patent/CN109641006A/zh
Application granted granted Critical
Publication of CN109641006B publication Critical patent/CN109641006B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201780051160.0A 2016-06-22 2017-06-22 影响肠道微生物组成的微生物类胡萝卜素 Active CN109641006B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16175832.1 2016-06-22
EP16175832 2016-06-22
PCT/EP2017/065348 WO2017220708A1 (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Publications (2)

Publication Number Publication Date
CN109641006A CN109641006A (zh) 2019-04-16
CN109641006B true CN109641006B (zh) 2022-07-01

Family

ID=56203217

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780051160.0A Active CN109641006B (zh) 2016-06-22 2017-06-22 影响肠道微生物组成的微生物类胡萝卜素

Country Status (12)

Country Link
US (1) US11324717B2 (cg-RX-API-DMAC7.html)
EP (1) EP3474862B1 (cg-RX-API-DMAC7.html)
JP (1) JP6966543B2 (cg-RX-API-DMAC7.html)
KR (1) KR102413408B1 (cg-RX-API-DMAC7.html)
CN (1) CN109641006B (cg-RX-API-DMAC7.html)
AU (1) AU2017281589B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018076485A8 (cg-RX-API-DMAC7.html)
CA (1) CA3028031C (cg-RX-API-DMAC7.html)
IL (1) IL263683B (cg-RX-API-DMAC7.html)
MX (1) MX390386B (cg-RX-API-DMAC7.html)
RU (1) RU2759600C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017220708A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10220089B2 (en) 2012-08-29 2019-03-05 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
AU2015339284B2 (en) 2014-10-30 2021-08-05 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
WO2018148220A1 (en) * 2017-02-07 2018-08-16 California Institute Of Technology Modulation of gut microbiota in huntington's disease and rett syndrome
EP3720458A4 (en) 2017-12-05 2021-12-08 BioPlx, Inc. METHODS AND COMPOSITIONS FOR PREVENTING MICROBIAL INFECTION
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
KR102369996B1 (ko) * 2020-04-21 2022-03-02 박선민 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用
CN119184223A (zh) * 2024-10-14 2024-12-27 元医(杭州)科技有限公司 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
GB0524873D0 (en) * 2005-12-06 2006-01-11 New Royal Holloway & Bedford Bacterial production of carotenoids
GB201013041D0 (en) * 2010-08-03 2010-09-15 Royal Holloway & New Bedford College Carotenoids

Also Published As

Publication number Publication date
RU2019101481A (ru) 2020-07-22
CA3028031C (en) 2023-02-28
AU2017281589B2 (en) 2023-03-23
US20190209516A1 (en) 2019-07-11
KR102413408B1 (ko) 2022-06-27
CA3028031A1 (en) 2017-12-28
BR112018076485A2 (pt) 2019-04-09
IL263683A (en) 2019-01-31
EP3474862B1 (en) 2025-10-29
BR112018076485A8 (pt) 2022-12-06
JP6966543B2 (ja) 2021-11-17
KR20190039687A (ko) 2019-04-15
RU2019101481A3 (cg-RX-API-DMAC7.html) 2020-10-16
MX390386B (es) 2025-03-20
RU2759600C2 (ru) 2021-11-16
CN109641006A (zh) 2019-04-16
US11324717B2 (en) 2022-05-10
JP2019524877A (ja) 2019-09-05
AU2017281589A1 (en) 2019-01-31
MX2018016118A (es) 2019-07-08
WO2017220708A1 (en) 2017-12-28
EP3474862A1 (en) 2019-05-01
IL263683B (en) 2022-04-01

Similar Documents

Publication Publication Date Title
CN109641006B (zh) 影响肠道微生物组成的微生物类胡萝卜素
Chen et al. Orally administered CLA ameliorates DSS-induced colitis in mice via intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokine and gut microbiota modulation
Shang et al. In vitro and in vivo antioxidant activities of inulin
Zhao et al. Bacillus coagulans 13002 and fructo-oligosaccharides improve the immunity of mice with immunosuppression induced by cyclophosphamide through modulating intestinal-derived and fecal microbiota
Zhang et al. Foodborne carbon dot exposure induces insulin resistance through gut microbiota dysbiosis and damaged intestinal mucus layer
Tlaskalova-Hogenova et al. Microbiome and colorectal carcinoma: insights from germ-free and conventional animal models
Yarahmadi et al. Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review
Chen et al. The beneficial mechanism of chitosan and chitooligosaccharides in the intestine on different health status
Chang et al. Effects of different oligosaccharides on growth performance and intestinal function in broilers
Wang et al. The effects of dietary ellagic acid supplementation on growth performance, immune response, antioxidant activity, digestive enzyme activities, and intestinal functions in yellow-feathered broilers
Bernabeu et al. The potential modulation of gut microbiota and oxidative stress by dietary carotenoid pigments
Cheng et al. Berberine alleviates high-energy and low-protein diet-induced fatty liver hemorrhagic syndrome in laying hens: insights from microbiome and metabolomics
Ayesiga et al. Key regulatory aspects of prebiotics, probiotics, and synbiotics in the management of metabolic disorders
CN107980002A (zh) 使用长双岐杆菌优化母乳喂养的方法和组合物
WO2023237674A1 (en) Vitamin b2 for use in improving gut health
Wu et al. Modulating microbiota as a new strategy for breast cancer prevention and treatment. Microorganisms. 2022; 10: 1727
Han et al. Postbiotics ameliorate DSS-induced colitis in mice by regulating gut microbiota, promoting tryptophan metabolism, and activating AhR/IL-22 signaling pathway
Sarojini Gut Microbes: The Miniscule Laborers in the Human Body
CN106974939B (zh) 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
Chandra Synbiotics in Nutrition
da FONSECA et al. The function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis: a systematic review.
Fonseca et al. Function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis (NASH): a systematic review: a systematic review
Yu of chenodeoxycholic acid and its
Lu et al. Effect of Glycyrrhiza uralensis extract, Lactobacillus acidophilus and their combined supplementation on production performance, immunity, antioxidation and intestinal health in broilers
KR20250022160A (ko) 비타민 c와 락토바실러스 람노서스를 포함하는 조합물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20211210

Address after: Ghent

Applicant after: Microbial research management health Co.,Ltd.

Address before: Ghent

Applicant before: ProDigest BVBA

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant